CC vs CVS · P/E 72, rev $1.36B vs P/E 16, rev $402.07B
Chemours Co (CC) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CC currently screens at market cap $1.94B and trailing P/E 71.8. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CC and CVS stock pages for the full models.
Not investment advice.